• Home >
  • Advances in Personalized Medicine (Technical Insights)

Advances in Personalized Medicine (Technical Insights)

 

23-Dec-2010  /  Research Code: D23E-01-00-00-00  /  SKU: HC01298-GL-TR_05578  /  
Region: Global

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service provides an assessment of key component technology and application areas within the personalized medicine space, and offers insights and recommendations for managing the R&D portfolio effectively. Incorporated analysis includes a strategic evaluation of R&D portfolio within this space using a multicriteria decision making tool, an assessment of research orientation among key focus areas in the industry, analysis of the challenging environment for R&D, and an overview of emerging market needs. Finally, a discussion of future R&D trends and insights on strategically managing the R&D pipeline is also included.

Table of Contents

Advances in Personalized Medicine (Technical Insights), Executive SummaryOverview; Scope and MethodologyAn Overview of Personalized MedicineResearch Service ScopeMethodology Executive SummaryKey Technology and Industry TrendsPerspectives for Industry DevelopmentAdvances in Personalized Medicine (Technical Insights), Technology Snapshot and Value Chain Costing AssessmentThe Path to Personalized MedicineTechnology Foundations Updates in Genomics and GeneticsTechnology Correlation in Personalized MedicineTechnology and Applications of Personalized MedicineTechnology Approaches Towards Personalized MedicineApplications of Personalized MedicineValue Chain AssessmentValue Chain AssessmentOverview of the Current Value Chain and Value Distribution of MedicineCost-Based Assessment of R&DTechnology Trend EvaluationDrivers and RestraintsChallengesAdvances in Personalized Medicine (Technical Insights), Stakeholder Industry Initiatives and Target ApplicationsOverview of Stakeholder EnvironmentOverview of Stakeholder EnvironmentAssessment of Competitive Behaviour in the IndustryKey Partnerships and InitiativesIndustrial and Academic InitiativesBusiness Models in Personalized MedicinePartnership and Alliance ModelsPersonalized Medicine Trends and Strategic RecommendationsMarket TrendsFinancial TrendsStrategic RecommendationsAdvances in Personalized Medicine (Technical Insights), Patents and Key Industry ParticipantsPatentsIndustrial PatentsAcademic PatentsKey ParticipantsAdvances in Personalized Medicine (Technical Insights), Decision Support Database TablesDecision Support TablesGlobal Number of Biotechnology Companies (2006 to 2016)Global Percentage Pharmaceutical R&D Expenditure (2006 to 2016)Global Pharmaceutical R&D Expenditure (2006 to 2016)




Related Research

Recent Advances in Targeted Therapies

Release Date : 08-Sep-17

Region : Global

Advances in Drug Discovery and Development

Release Date : 08-Sep-17

Region : Global

Recent Advances across the Cancer Immunotherapy Landscape

Release Date : 01-Sep-17

Region : Global

Medical Imaging Innovations in Ultrasound Systems, Artificial Intelligence, Endoscopy, OCT, and PET

Release Date : 25-Aug-17

Region : Global

Recent Advances across T cell-based Therapeutics

Release Date : 25-Aug-17

Region : Global

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.